“A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION”, Int. Res. J. Pharm., vol. 9, no. 5, pp. 90–99, May 2018, Accessed: Nov. 02, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/1071